Follow
Tamsin Robb
Tamsin Robb
Verified email at auckland.ac.nz
Title
Cited by
Cited by
Year
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
B Lawrence, C Blenkiron, K Parker, P Tsai, S Fitzgerald, P Shields, ...
NPJ Genomic Medicine 3 (1), 18, 2018
512018
Exploiting microRNAs as cancer therapeutics
T Robb, G Reid, C Blenkiron
Targeted oncology 12 (2), 163-178, 2017
282017
A predictor of early disease recurrence in patients with breast cancer using a cell-free RNA and protein liquid biopsy
A Lasham, SJ Fitzgerald, N Knowlton, T Robb, P Tsai, MA Black, ...
Clinical Breast Cancer 20 (2), 108-116, 2020
132020
Reviving the Autopsy for Modern Cancer Evolution Research
TJ Robb, R Tse, C Blenkiron
Cancers 13 (3), 409, 2021
92021
Tailoring a rapid autopsy protocol to explore cancer evolution: a patient collaboration
C Blenkiron, B Lawrence, T Robb, K Parker, N Kramer, S Stables, R Tse, ...
The New Zealand medical journal (Online) 132 (1503), 83-92, 2019
62019
Merkel cell polyomavirus is uncommon in New Zealand Merkel cell carcinomas.
B Woodhouse, TJ Robb, JI Hearn, PS Houseman, G Hayward, R Miller, ...
The British journal of dermatology 179 (5), 1197, 2018
62018
Chromosomal Aberrations Accumulate During Metastasis of Virus-negative Merkel Cell Carcinoma
TJ Robb, Z Ward, P Houseman, B Woodhouse, R Patel, S Fitzgerald, ...
Journal of Investigative Dermatology, 2023
22023
Complex patterns of genomic heterogeneity identified in 42 tumor samples and ctDNA of a pulmonary atypical carcinoid patient
TJ Robb, P Tsai, S Fitzgerald, P Shields, PS Houseman, R Patel, V Fan, ...
Cancer Research Communications 3 (1), 31-42, 2023
22023
Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving Immunotherapy
S Fitzgerald, C Blenkiron, R Stephens, JA Mathy, T Somers-Edgar, ...
Molecular Diagnosis & Therapy, 1-14, 2023
12023
Tumour evolution in a single patient
TJ Robb
PhD Thesis-University of Auckland, 2021
12021
Application of forensic post-mortem techniques in a rapid autopsy to facilitate cancer research-an illustrative case report
R Tse, T Robb, S Stables, N Kramer, K Parker, E Coats, C Blenkiron, ...
Australian Journal of Forensic Sciences, 1-7, 2024
2024
Clonal or collision? A tale of two MiNENs
J Choi, T Robb, S Fitzgerald, PLQ Stabej, P Tsai, P Restall, B Lawrence
Pathology 56, S51, 2024
2024
XR Tumor Evolution Project: A Hybrid Architectural Space for Cancer Research
M Davis, D Hurley, B Lawrence, Y Liu, U Rieger, T Robb, C Windahl, ...
Hybrids & Haecceities: Projects Catalog of the 42nd Annual Conference for …, 2022
2022
366 Genomic profile of clear cell ovarian cancers and evolution with disease progression
S Mesnage, T Robb, C Blenkiron, K Payne, H Hameed, P Shields, ...
International Journal of Gynecologic Cancer 30 (Suppl 3), 2020
2020
Make Friends with Other Disciplines: Building novel collaborations to drive novel research
T Robb, B Haux
The University of Auckland, 2019
2019
Understanding Tumour Evolution of a Highly Disseminated Lung NET Through Multi-Player Augmented Reality Visualisation
T Robb, B Haux, B Woodhouse, K Parker, C Blenkiron, P Tsai, N Young, ...
NEUROENDOCRINOLOGY 108, 33-33, 2019
2019
Spatial Proteomics Approach Identifies Novel Immuno-Oncology Markers for Merkel Cell Carcinoma
C Blenkiron, K Parker, P Houseman, B Woodhouse, T Robb, B Lawrence, ...
NEUROENDOCRINOLOGY 108, 2-2, 2019
2019
Investigating tumour evolution in a single patient with disseminated cancer
T Robb, C Blenkiron, P Tsai, K Parker, A Drummond, M Black, ...
ANNALS OF ONCOLOGY 29, 156-156, 2018
2018
507P Investigating tumour evolution in a single patient with disseminated cancer
T Robb, C Blenkiron, P Tsai, K Parker, A Drummond, M Black, ...
Annals of Oncology 29 (suppl_9), mdy425. 018, 2018
2018
Enhancing Diagnostic Precision Through Combined Genomic and Histopathological Analysis of Pancreatic Neuroendocrine Tumors
T Robb, ML Yeong, N Kramer, C Blenkiron, K Parker, P Tsai, S Fitzgerald, ...
NEUROENDOCRINOLOGY 106, 36-36, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20